Evidence map›Paper›PMID 36701593›Full record

ReviewDiabetes care2023

The National Clinical Care Commission Report to Congress: Leveraging Federal Policies and Programs to Improve Diabetes Treatment and Reduce Complications.

M Carol Greenlee, Shari Bolen, William Chong, Ayotunde Dokun, Jasmine Gonzalvo, Meredith Hawkins, William H Herman, Ellen Leake, Barbara Linder, Paul R Conlin

Abstract readReview
In one paragraph

Review in Diabetes care, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Rethinking diabetes in the United States.Frontiers in endocrinology · 2023
    Article
  12. Roadmaps to Continuous Glucose Monitoring's Role in Transforming Diabetes Management.Diabetes spectrum : a publication of the American Diabetes Association · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

M Carol GreenleeWestern Slope Endocrinology, Grand Junction, CO.
Shari BolenPopulation Health Research Institute and Center for Health Care Research and Policy, Case Western Reserve at The MetroHealth System, Cleveland, OH.
William ChongOffice of Generic Drugs, Center for Drug Evaluation and Research, Food and Drug Administration, Rockville, MD.
Ayotunde DokunDivision of Endocrinology and Metabolism, Carver School of Medicine, University of Iowa, Iowa City, IA.
Jasmine GonzalvoCenter for Health Equity and Innovation, Purdue University, Indianapolis, IN.
Meredith HawkinsGlobal Diabetes Institute, Albert Einstein College of Medicine, Bronx, NY.
William H HermanUniversity of Michigan, Ann Arbor, MI.ORCID 0000-0002-0502-674X
Ellen LeakeJuvenile Diabetes Research Foundation, Jackson, MS.
Barbara LinderNational Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD.
Paul R ConlinDepartment of Veterans Affairs Boston Healthcare System, Boston, MA.

Funding

Research BaseP30DK092926 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MARY ELLEN MICHELE HEISLER, ADESUWA B OLOMU · 2011 to 2026
$10.0M
AHRQ HHSCDC HHSFDA HHSHRSA HHSNIDDK NIH HHS P30 DK092926
6 · The paper itself

Abstract

The Treatment and Complications subcommittee of the National Clinical Care Commission focused on factors likely to improve the delivery of high-quality care to all people with diabetes. The gap between available resources and the needs of people living with diabetes adversely impacts both treatment and outcomes. The Commission's recommendations are designed to bridge this gap. At the patient level, the Commission recommends reducing barriers and streamlining administrative processes to improve access to diabetes self-management training, diabetes devices, virtual care, and insulin. At the practice level, we recommend enhancing programs that support team-based care and developing capacity to support technology-enabled mentoring interventions. At the health system level, we recommend that the Department of Health and Human Services routinely assess the needs of the health care workforce and ensure funding of training programs directed to meet those needs. At the health policy level, we recommend establishing a process to identify and ensure pre-deductible insurance coverage for high-value diabetes treatments and services and developing a quality measure that reduces risk of hypoglycemia and enhances patient safety. We also identified several areas that need additional research, such as studying the barriers to uptake of diabetes self-management education and support, exploring methods to implement team-based care, and evaluating the importance of digital connectivity as a social determinant of health. The Commission strongly encourages Congress, the Department of Health and Human Services, and other federal departments and agencies to take swift action to implement these recommendations to improve health outcomes and quality of life among people living with diabetes.

Indexed as

Diabetes MellitusQuality of LifeHealth PolicyHumans

Identifiers

PMID36701593
PMCPMC9887628

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.